Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3F6V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,328
Award facts
- Contract value 100% obligated
- $19,328.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Dupixent 300 mg/2 mL pen auto-injectors with a firm fixed price ceiling value of $19,328.35 and an ultimate completion date of December 2, 2025. This non-set-aside delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated extensive capability in fulfilling Defense Logistics Agency requirements through competitively awarded contracts covering a broad portfolio of pharmaceutical products and medical supplies. Dupixent (dupilumab) is a biologic immunosuppressant used primarily in the treatment of atopic dermatitis, eosinophilic esophagitis, and severe asthma. The delivery order represents routine pharmaceutical procurement under the broader DLA Troop Support Medical prime vendor contract, which enables the company to supply the Department of Defense, Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with essential medications and medical commodities to support military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F3F6V?
SPE2DR26F3F6V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F3F6V worth?
The government has obligated $19,328 on SPE2DR26F3F6V.
Is contract SPE2DR26F3F6V an order under another contract?
Yes. SPE2DR26F3F6V is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3F6V competed?
The extent of competition for SPE2DR26F3F6V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award